The final rules were submitted Sept. 3 and are listed as “pending review” in the OMB’s list of regulatory actions.
Some of the key changes for the 2015-2017 modification rule include a 90-day reporting period instead of the current one-year reporting period, as well as revised stage 2 requirements offering providers certain exemptions and flexibilities.
Proposed rules for stage 3 of the meaningful use program are slated to be the final stage of the Federal EHR Incentive Program. As currently proposed, all providers would begin attesting to stage 3 in 2018, regardless of their current stage.
More articles on meaningful use:
Has MU failed its mission?
Hospital groups urge HHS to finalize MU Stage 2 rules
15 thoughts on interoperability from healthcare leaders
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
